Actively Recruiting
Phase 3 Study Comparing Digital and Standard Care Plans for Adults with Advanced Sarcomas Receiving Systemic Treatment
Led by Centre Oscar Lambret · Updated on 2026-03-18
377
Participants Needed
11
Research Sites
91 weeks
Total Duration
AI-Summary
What This Trial Is About
This research investigates the benefits of a digital personalized care plan PCP compared to the standard PCP for patients with advanced sarcomas receiving systemic treatment. The study focuses on patients with metastatic or locally advanced soft tissue or visceral sarcomas who are treated with specific monotherapies such as pazopanib, trabectedine, eribulin, ifosfamide, or dacarbazine. The trial is a phase 3, randomized, open-label, controlled, multicenter study assessing the impact of these care plans on patient outcomes. Participants are randomly assigned to one of two groups. The experimental group receives both the standard PCP and a dematerialized digital personalized care plan, while the control group receives only the standard PCP. Patients continue treatment and follow-up until the end of second-line treatment, the start of a new treatment line, or up to 24 months. The main goal is to compare the occurrence of severe adverse events during the first three months of second-line treatment between the two groups. Throughout the study, participants will be monitored for severe toxicity, progression-free survival, overall survival, types of severe adverse events, hospitalizations due to adverse events, and quality of life using a specific questionnaire. Data collection continues for up to 24 months, with particular focus on the first three months of second-line therapy. This monitoring ensures careful evaluation of patient safety, treatment effects, and quality of life during the study period.
CONDITIONS
Brief Title
Superiority Trial Evaluating Digitalized Information Media for Patients With Advanced Sarcomas Receiving Systemic Treatment.
Research Team
P
PANNIER Diane, DR
T
THERY Julien, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here